20 August 2018 - A controversial FDA working group has begun discussing how to import drugs from other countries as a way of bringing down prices for American patients, a top Trump administration health official said Monday.
“That work group has met and is outlining its plan of action,” Dan Best, senior adviser on drug pricing, said on a phone call with reporters.
“As more of that information becomes available, we’ll make it available to the market.”